Trials / Unknown
UnknownNCT03979404
Theta Burst Stimulation in Anorexia Nervosa: A Case Series
A Feasibility Case Series of Theta Burst Stimulation in Anorexia Nervosa
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 13 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Anorexia Nervosa (AN) is a life-threatening eating disorder characterised by an intense fear of weight gain and disturbed body image, which motivates severe dietary restriction or other weight loss behaviours (e.g. purging). Treatment efficacy in adults with AN remains low: only a small percentage of individuals fully recover, and dropout rates are high. For adolescents with a relatively short term illness duration (under 3 years), family-based therapy has been associated with more favourable outcomes. However, for those adolescents with a longer illness duration (over 3 years), there are no specific treatments associated with positive long-term outcomes and these individuals are at risk of developing a severe and enduring form of the illness (SE-AN). In part, treatment can be problematic due to ambivalence, which is reflected in poor take-up of certain treatments (e.g. pharmacological treatments that lead to weight gain) and high drop-out rates. Repetitive transcranial magnetic stimulation (rTMS) has demonstrated efficacy for treatment of AN in adults and improving treatment adherence. However, this has yet to be investigated in adolescents with AN. This study will use a novel type of rTMS, called intermittent theta burst stimulation (iTBS). TBS takes as little as a few minutes duration compared to the classical rTMS protocol which takes approximately 37.5 minutes. In addition, TBS has been found to produce longer after-effects of the induced plastic changes and has a lower stimulation intensity, which may therefore be more practical and potentially safer to administer in people with AN. Thus, the aim of this feasibility case series is to obtain preliminary data on the longer-term (i.e. up to 6 months) effects of 20 sessions of iTBS on reducing core symptoms of AN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intermittent Theta Burst Stimulation | The Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer active TBS. |
Timeline
- Start date
- 2020-02-18
- Primary completion
- 2022-12-01
- Completion
- 2023-01-01
- First posted
- 2019-06-07
- Last updated
- 2022-08-19
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03979404. Inclusion in this directory is not an endorsement.